Noxopharm

(ASX) NOX

Current Price$0.07

Market Cap$21.51M

Since IPO (2016)-57%

5 Year-88%

1 Year-3%

1 Month+29%

Noxopharm Financials at a Glance

Market Cap

$21.51M

Revenue (TTM)

$4.01M

Net Income (TTM)

$7.81M

EPS (TTM)

$-0.02

P/E Ratio

-3.72

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$0.07

Volume

36,726

Open

$0.07

Price

$0.07

Volume

36,726

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.04 - $0.14

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$0.07

Volume

36,726

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.04 - $0.14

NOX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Noxopharm

Industry

Biotechnology

Sector

Health Care

CEO

Gisela Mautner, MD, PhD

Website

www.noxopharm.com

Headquarters

Chatswood, NSW 2067, AU

NOX Financials

Key Financial Metrics (TTM)

Gross Margin

-63%

Operating Margin

-5%

Net Income Margin

-3%

Return on Equity

-344%

Return on Capital

Return on Assets

-1%

Earnings Yield

-26.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.51M

Shares Outstanding

307.24M

Volume

36.73K

Avg. Volume

165.07K

Financials (TTM)

Gross Profit

$1.45M

Operating Income

$9.65M

EBITDA

$5.38M

Operating Cash Flow

$5.82M

Capital Expenditure

$0.00

Free Cash Flow

$5.82M

Cash & ST Invst.

$1.55M

Total Debt

$2.48M

Noxopharm Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$879.00

-100.1%

Gross Margin

0.00%

N/A

Market Cap

$21.51M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.84M

+26.3%

EBITDA

$3.02M

+18.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$4.15M

-180.5%

Accounts Receivable

$4.61M

+287.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$4.25M

N/A

Return on Assets

-1.16%

N/A

Return on Invested Capital

7.98%

N/A

Free Cash Flow

$4.56M

+44.6%

Operating Cash Flow

$4.56M

+44.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IDT.AXIDT Australia Limited

IDT.AXIDT Australia Limited$0.04+0.00%

NC6.AXNanollose Limited

NC6.AXNanollose Limited$0.08-3.70%

BDX.AXBCAL Diagnostics Limited

BDX.AXBCAL Diagnostics Limited$0.08+0.00%

PAB.AXPatrys Limited

PAB.AXPatrys Limited$0.03+1.69%

OSL.AXOncoSil Medical Limited

OSL.AXOncoSil Medical Limited$0.52+5.10%

TRP.AXTissue Repair Ltd

TRP.AXTissue Repair Ltd$0.13+0.00%

IMC.AXImmuron Limited

IMC.AXImmuron Limited$0.03+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.05+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.68+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.33+0.03%

NIONio

NIONio$5.92-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.21-0.03%

MARAMara Holdings

MARAMara Holdings$11.44-0.05%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About NOX

What is the current price of Noxopharm?

Noxopharm is trading at A$0.08 per share.

What is the 52-week range for Noxopharm?

Over the past 52 weeks, Noxopharm has traded between A$0.04 and A$0.14.

How much debt does Noxopharm have?

As of the most recent reporting period, Noxopharm reported total debt of $2.48M.

How much cash does Noxopharm have on hand?

Noxopharm reported $1.55M in cash and cash equivalents in its most recent financial results.

What is Noxopharm’s dividend yield?

Noxopharm does not currently have a dividend yield.

Noxopharm

Noxopharm Financials at a Glance

NOX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Noxopharm

NOX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Noxopharm Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NOX

What is the current price of Noxopharm?

What is the 52-week range for Noxopharm?

How much debt does Noxopharm have?

How much cash does Noxopharm have on hand?

What is Noxopharm’s dividend yield?

Premium Investing Services